...
机译:STAT3抑制抑制肝星状细胞纤维发生:HJC0123,肝纤维化的潜在治疗剂
Univ Texas Med Branch Dept Surg 301 Univ Blvd Galveston TX 77555 USA;
Univ Texas Med Branch Dept Surg 301 Univ Blvd Galveston TX 77555 USA;
Univ Texas Med Branch Dept Surg 301 Univ Blvd Galveston TX 77555 USA;
Univ Texas Med Branch Dept Pharmacol &
Toxicol 301 Univ Blvd Galveston TX 77555 USA;
Univ Texas Med Branch Dept Surg 301 Univ Blvd Galveston TX 77555 USA;
Univ Texas Med Branch Dept Surg 301 Univ Blvd Galveston TX 77555 USA;
Univ Texas Med Branch Dept Pharmacol &
Toxicol 301 Univ Blvd Galveston TX 77555 USA;
Univ Texas Med Branch Dept Pharmacol &
Toxicol 301 Univ Blvd Galveston TX 77555 USA;
Univ Texas Med Branch Dept Pharmacol &
Toxicol 301 Univ Blvd Galveston TX 77555 USA;
Univ Texas Med Branch Dept Surg 301 Univ Blvd Galveston TX 77555 USA;
机译:STAT3抑制抑制肝星状细胞纤维发生:HJC0123,肝纤维化的潜在治疗剂
机译:Moniliformediquinone作为潜在的治疗剂,可在体内灭活肝星状细胞并抑制肝纤维化
机译:小ber碱对大鼠肝纤维化模型和肝星状细胞中纤维发生的抑制作用
机译:纳米级三黄泻心汤抑制肝星状细胞TGF-β_1的活化和纤维化
机译:血小板源性生长因子受体α在慢性肝损伤中的新兴作用:肝纤维化的潜在治疗靶点。
机译:STAT3抑制抑制肝星状细胞纤维化:HJC0123肝纤维化的潜在治疗剂
机译:STAT3抑制抑制肝星状细胞纤维发生:HJC0123,肝纤维化的潜在治疗剂